{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:18:10Z","timestamp":1779931090127,"version":"3.53.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701570"],"award-info":[{"award-number":["81701570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"345 Talent Project of Shengjing hospital of China Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Colon cancer is the foremost reason of cancer-related mortality worldwide. Colon adenocarcinoma constitutes 90% of colon cancer, and most patients with colon adenocarcinoma (COAD) are identified until advanced stage. With the emergence of an increasing number of novel pathogenic mechanisms and treatments, the role of mitochondria in the development of cancer, has been studied and reported with increasing frequency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We systematically analyzed the effect of mitochondria-related genes in COAD utilizing RNA sequencing dataset from The Cancer Genome Atlas database and 1613 mitochondrial function-related genes from MitoMiner database. Our approach consisted of differentially expressed gene, gene set enrichment analysis, gene ontology terminology, Kyoto Encyclopedia of Genes and Genomes, independent prognostic analysis, univariate and multivariate analysis, Kaplan\u2013Meier survival analysis, immune microenvironment correlation analysis, and Cox regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Consequently, 8 genes were identified to construct 8 mitochondrial-related gene model by applying Cox regression analysis, CDC25C, KCNJ11, NOL3, P4HA1, QSOX2, Trap1, DNAJC28, and ATCAY. Meanwhile, we assessed the connection between this model and clinical parameters or immune microenvironment. Risk score was an independent predictor for COAD patients\u2019 survival with an AUC of 0.687, 0.752 and 0.762 at 1-, 3- and 5-year in nomogram, respectively. The group with the highest risk score had the lowest survival rate and the worst clinical stages. Additionally, its predictive capacity was validated in GSE39582 cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In summary, we established a prognostic pattern of mitochondrial-related genes, which can predict overall survival in COAD, which may enable a more optimized approach for the clinical treatment and scientific study of COAD. This gene signature model has the potential to improve prognosis and treatment for COAD patients in the future, and to be widely implemented in clinical settings. The utilization of this mitochondrial-related gene signature model may be benefit in the treatments and medical decision-making of COAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-02020-3","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T11:40:28Z","timestamp":1666438828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Hongli","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145\u201364.","journal-title":"CA Cancer J Clin"},{"key":"2020_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","volume":"365","author":"J Weitz","year":"2005","unstructured":"Weitz J, Koch M, Debus J, H\u00f6hler T, Galle PR, B\u00fcchler MW. Colorectal cancer. Lancet. 2005;365:153\u201365.","journal-title":"Lancet"},{"key":"2020_CR3","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/annonc\/mdz287","volume":"30","author":"R Dienstmann","year":"2019","unstructured":"Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, et al. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II\/III colorectal cancer. Ann Oncol. 2019;30:1622\u20139.","journal-title":"Ann Oncol"},{"key":"2020_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3816\/CCC.2011.n.002","volume":"10","author":"LJW Bosch","year":"2011","unstructured":"Bosch LJW, Carvalho B, Fijneman RJA, Jimenez CR, Pinedo HM, van Engeland M, et al. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer. 2011;10:8\u201323.","journal-title":"Clin Colorectal Cancer"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.mayocp.2018.03.010","volume":"93","author":"LA Erickson","year":"2018","unstructured":"Erickson LA. Adenocarcinoma of the colon and microsatellite instability. Mayo Clin Proc. 2018;93:669\u201370.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","volume":"52","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, et al. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat Genet. 2020;52(3):342\u201352.","journal-title":"Nat Genet"},{"key":"2020_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138.","journal-title":"Nature"},{"key":"2020_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.trsl.2018.07.013","volume":"202","author":"S Pustylnikov","year":"2018","unstructured":"Pustylnikov S, Costabile F, Beghi S, Facciabene A. Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Transl Res. 2018;202:35\u201351.","journal-title":"Transl Res"},{"key":"2020_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke PJ. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer. 2017;3:857\u201370.","journal-title":"Trends Cancer"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555\u201366.","journal-title":"Cell"},{"key":"2020_CR11","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1038\/s41388-019-0949-5","volume":"38","author":"Y Han","year":"2019","unstructured":"Han Y, Kim B, Cho U, Park IS, Kim SI, Dhanasekaran DN, et al. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. 2019;38:7089\u2013105.","journal-title":"Oncogene"},{"key":"2020_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221671","volume":"14","author":"BA Kaipparettu","year":"2019","unstructured":"Kaipparettu BA, Ma Y, Park JH, Lee T-L, Zhang Y, Yotnda P, et al. Correction: crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS ONE. 2019;14: e0221671.","journal-title":"PLoS ONE"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.molcel.2018.01.037","volume":"69","author":"MD Cardamone","year":"2018","unstructured":"Cardamone MD, Tanasa B, Cederquist CT, Huang J, Mahdaviani K, Li W, et al. Mitochondrial retrograde signaling in mammals is mediated by the transcriptional cofactor GPS2 via direct mitochondria-to-nucleus translocation. Mol Cell. 2018;69:757\u2013772.e7.","journal-title":"Mol Cell"},{"key":"2020_CR14","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.2147\/IJN.S272378","volume":"15","author":"VC Kok","year":"2020","unstructured":"Kok VC, Yu CC. Cancer-derived exosomes: their role in cancer biology and biomarker development. Int J Nanomedicine. 2020;15:8019\u201336.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1039\/C4CS00370E","volume":"44","author":"L Wu","year":"2015","unstructured":"Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev. 2015;44(10):2963\u201397.","journal-title":"Chem Soc Rev"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"D1225","DOI":"10.1093\/nar\/gky1072","volume":"47","author":"AC Smith","year":"2018","unstructured":"Smith AC, Robinson AJ. MitoMiner v4.0: an updated database of mitochondrial localization evidence, phenotypes and diseases. Nucleic Acids Res. 2018;47:D1225-1228.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e47.","journal-title":"Nucleic Acids Res"},{"key":"2020_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"2020_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351.","journal-title":"Protein Sci"},{"key":"2020_CR20","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49:D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol. 2012;16(5):284\u20137.","journal-title":"Omics J Integr Biol"},{"key":"2020_CR22","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. 2016; ISBN 978-3-319-24277-4. https:\/\/ggplot2.tidyverse.org."},{"issue":"17","key":"2020_CR23","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912\u20134.","journal-title":"Bioinformatics."},{"key":"2020_CR24","unstructured":"https:\/\/rpkgs.datanovia.com\/survminer\/index.html"},{"key":"2020_CR25","unstructured":"https:\/\/cran.r-project.org\/web\/packages\/survivalROC\/survivalROC.pdf"},{"key":"2020_CR26","unstructured":"https:\/\/cran.r-project.org\/web\/packages\/beeswarm\/beeswarm.pdf"},{"key":"2020_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3590","volume":"354","author":"SG Thrumurthy","year":"2016","unstructured":"Thrumurthy SG, Thrumurthy SSD, Gilbert CE, Ross P, Haji A. Colorectal adenocarcinoma: risks, prevention and diagnosis. BMJ. 2016;354: i3590.","journal-title":"BMJ"},{"key":"2020_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","volume":"26","author":"S Arena","year":"2020","unstructured":"Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, et al. A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin. Clin Cancer Res. 2020;26:1372\u201384.","journal-title":"Clin Cancer Res"},{"key":"2020_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188334","volume":"1873","author":"N Seiwert","year":"2020","unstructured":"Seiwert N, Heylmann D, Hasselwander S, Fahrer J. Mechanism of colorectal carcinogenesis triggered by heme iron from red meat. Biochim Biophys Acta Rev Cancer. 2020;1873: 188334.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2020_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40880-019-0361-0","volume":"39","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019;39:13.","journal-title":"Cancer Commun (Lond)"},{"key":"2020_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2019.01.001","volume":"692","author":"L Chen","year":"2019","unstructured":"Chen L, Lu D, Sun K, Xu Y, Hu P, Li X, et al. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Gene. 2019;692:119\u201325.","journal-title":"Gene"},{"key":"2020_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12935-018-0724-7","volume":"19","author":"S Zuo","year":"2019","unstructured":"Zuo S, Dai G, Ren X. Identification of a 6-gene signature predicting prognosis for colorectal cancer. Cancer Cell Int. 2019;19:6.","journal-title":"Cancer Cell Int"},{"key":"2020_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100940","volume":"54","author":"M Akbari","year":"2019","unstructured":"Akbari M, Kirkwood TBL, Bohr VA. Mitochondria in the signaling pathways that control longevity and health span. Ageing Res Rev. 2019;54: 100940.","journal-title":"Ageing Res Rev"},{"key":"2020_CR34","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/brv.12291","volume":"92","author":"RE Koch","year":"2017","unstructured":"Koch RE, Josefson CC, Hill GE. Mitochondrial function, ornamentation, and immunocompetence. Biol Rev Camb Philos Soc. 2017;92:1459\u201374.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"6","key":"2020_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13(6):472\u201382.","journal-title":"Cancer Cell"},{"issue":"1","key":"2020_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015;11(1):9\u201315.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"2020_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265\u201380.","journal-title":"Cell Res"},{"issue":"1","key":"2020_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-016-0712-6","volume":"18","author":"M Peiris-Pag\u00e8s","year":"2016","unstructured":"Peiris-Pag\u00e8s M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Res. 2016;18(1):55.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2020_CR39","doi-asserted-by":"publisher","first-page":"BSR20203481","DOI":"10.1042\/BSR20203481","volume":"41","author":"L-R Yan","year":"2021","unstructured":"Yan L-R, Wang A, Lv Z, Yuan Y, Xu Q. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer. Biosci Rep. 2021;41(1):BSR20203481.","journal-title":"Biosci Rep."},{"key":"2020_CR40","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1535-7163.MCT-16-0048","volume":"15","author":"I Buondonno","year":"2016","unstructured":"Buondonno I, Gazzano E, Jean SR, Audrito V, Kopecka J, Fanelli M, et al. Mitochondria-targeted doxorubicin: a new therapeutic strategy against doxorubicin-resistant osteosarcoma. Mol Cancer Ther. 2016;15:2640\u201352.","journal-title":"Mol Cancer Ther"},{"key":"2020_CR41","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J, et al. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231:2570\u201381.","journal-title":"J Cell Physiol"},{"key":"2020_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","volume":"56","author":"JC Schell","year":"2014","unstructured":"Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J, et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell. 2014;56:400\u201313.","journal-title":"Mol Cell"},{"key":"2020_CR43","first-page":"899","volume":"2","author":"S Feng","year":"2011","unstructured":"Feng S, Xiong L, Ji Z, Cheng W, Yang H. Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett. 2011;2:899\u2013903.","journal-title":"Oncol Lett"},{"key":"2020_CR44","first-page":"232","volume":"17","author":"NP Jones","year":"2012","unstructured":"Jones NP, Schulze A. Targeting cancer metabolism-Aiming at a tumour\u2019s sweet-spot. Drug Discov. 2012;17:232\u201341.","journal-title":"Drug Discov"},{"key":"2020_CR45","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo A, Gui DY, Heiden MGV. Targeting metabolism for cancer therapy. Cell Chem Biol. 2017;24:1161\u201380.","journal-title":"Cell Chem Biol"},{"issue":"9","key":"2020_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/138955709788922610","volume":"9","author":"A Mar\u00edn-Hern\u00e1ndez","year":"2009","unstructured":"Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC, Ralph SJ, Rodr\u00edguez-Enr\u00edquez S, Moreno-S\u00e1nchez R. HIF-1\u03b1 modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 2009;9(9):1084\u2013101.","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"2020_CR47","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3(3):187\u201397.","journal-title":"Cell Metab"},{"issue":"10","key":"2020_CR48","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/sj.bjc.6605026","volume":"100","author":"S Rasheed","year":"2009","unstructured":"Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, McDonald PJ, et al. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. Br J Cancer. 2009;100(10):1666\u201373.","journal-title":"Br J Cancer"},{"issue":"6090","key":"2020_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.1218099","volume":"337","author":"DK Bricker","year":"2012","unstructured":"Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science. 2012;337(6090):96\u2013100.","journal-title":"Science"},{"issue":"3","key":"2020_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","volume":"56","author":"JC Schell","year":"2014","unstructured":"Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J, et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell. 2014;56(3):400\u201313.","journal-title":"Mol Cell"},{"issue":"5","key":"2020_CR51","first-page":"899","volume":"2","author":"S Feng","year":"2011","unstructured":"Feng S, Xiong L, Ji Z, Cheng W, Yang H. Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett. 2011;2(5):899\u2013903.","journal-title":"Oncol Lett"},{"key":"2020_CR52","first-page":"5366185","volume":"2022","author":"YP Li","year":"2022","unstructured":"Li YP, Liu GX, Wu ZL, Tu PH, Wei G, Yuan M, et al. A novel mitochondrial-related gene signature for the tumor immune microenvironment evaluation and prognosis prediction in lung adenocarcinoma. J Immunol Res. 2022;2022:5366185.","journal-title":"J Immunol Res"},{"key":"2020_CR53","first-page":"1592905","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y, Song F, Zhang X, Yang C. Mitochondrial-related transcriptome feature correlates with prognosis, vascular invasion, tumor microenvironment, and treatment response in hepatocellular carcinoma. Oxid Med Cell Longev. 2022;2022:1592905.","journal-title":"Oxid Med Cell Longev"},{"key":"2020_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.746029","volume":"11","author":"X Jiang","year":"2021","unstructured":"Jiang X, Xia Y, Meng H, Liu Y, Cui J, Huang H, et al. Identification of a nuclear mitochondrial-related multi-genes signature to predict the prognosis of bladder cancer. Front Oncol. 2021;11:1.","journal-title":"Front Oncol"},{"key":"2020_CR55","first-page":"1","volume":"9","author":"X Zhang","year":"2021","unstructured":"Zhang X, Dong W, Zhang J, Liu W, Yin J, Shi D, et al. A novel mitochondrial-related nuclear gene signature predicts overall survival of lung adenocarcinoma patients. Front Cell Dev Biol. 2021;9:1.","journal-title":"Front Cell Dev Biol"},{"key":"2020_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Gene Ontol Consort Nat Genet. 2000;25:25\u20139.","journal-title":"Gene Ontol Consort Nat Genet"},{"key":"2020_CR57","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2020_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt S-M. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2020_CR59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis CA, Kimmelman AC. Metabolic Interactions in the Tumor Microenvironment. Trends Cell Biol. 2017;27:863\u201375.","journal-title":"Trends Cell Biol"},{"key":"2020_CR60","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell. 2012;22:547\u201360.","journal-title":"Cancer Cell"},{"key":"2020_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang X-Y, et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100.","journal-title":"Cancer Lett"},{"issue":"1","key":"2020_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","volume":"16","author":"B Jordan","year":"2019","unstructured":"Jordan B, Meeks J. T1 bladder cancer: current considerations for diagnosis and management. Nat Rev Urol. 2019;16(1):23\u201334.","journal-title":"Nat Rev Urol"},{"key":"2020_CR63","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/cr.2011.30","volume":"21","author":"W Wang","year":"2011","unstructured":"Wang W, Liu H, Wang S, Hao X, Li L. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt\/\u03b2-catenin signaling and colon cancer cell tumorigenesis. Cell Res. 2011;21:730\u201340.","journal-title":"Cell Res"},{"key":"2020_CR64","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1038\/s41467-018-05694-4","volume":"9","author":"C Wu","year":"2018","unstructured":"Wu C, Lyu J, Yang EJ, Liu Y, Zhang B, Shim JS. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells. Nat Commun. 2018;9:3212.","journal-title":"Nat Commun"},{"key":"2020_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.588811","volume":"11","author":"J Zhu","year":"2021","unstructured":"Zhu J, Wang S, Bai H, Wang K, Hao J, Zhang J, et al. Identification of five glycolysis-related gene signature and risk score model for colorectal cancer. Front Oncol. 2021;11: 588811.","journal-title":"Front Oncol"},{"key":"2020_CR66","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbrc.2019.06.096","volume":"516","author":"XP Cao","year":"2019","unstructured":"Cao XP, Cao Y, Li WJ, Zhang HH, Zhu ZM. P4HA1\/HIF1\u03b1 feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer. Biochem Biophys Res Commun. 2019;516:606\u201312.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-02020-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T01:07:40Z","timestamp":1666487260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-02020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-02020-3","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,22]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}